exo.incHealthcare / Medical DevicesFounded: 2016Funding to Date: $650.6MM
Exo is a developer of a high-performance handheld ultrasound platform.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/02/2021 | Series C | $220.75MM | $xx.xx | $636.17MM | Avidity Partners, Blackrock, Pura Vida Investments, Ra Capital Management, Sands Capital | |
Price per Share
$xx.xx
Shares Outstanding
37,684,090
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Avidity Partners, Blackrock, Pura Vida Investments, Ra Capital Management, Sands Capital
|
||||||
08/24/2020 | Series B+ | $49.7MM | $xx.xx | $256.65MM | Action Potential Venture Capital, Applied Ventures, Bold Capital, Creative Ventures, Fiscus Ventures, Innovation Growth Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, Osf Healthcare, Reimagined Ventures, Rising Tide Fund, Solasta Ventures, Tdk Ventures, Wanxiang Healthcare Investments | |
Price per Share
$xx.xx
Shares Outstanding
15,902,980
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Action Potential Venture Capital, Applied Ventures, Bold Capital, Creative Ventures, Fiscus Ventures, Innovation Growth Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, Osf Healthcare, Reimagined Ventures, Rising Tide Fund, Solasta Ventures, Tdk Ventures, Wanxiang Healthcare Investments
|
||||||
08/24/2020 | Series B++ | $3.7MM | $xx.xx | $256.65MM | Action Potential Venture Capital, Applied Ventures, Bold Capital, Creative Ventures, Fiscus Ventures, Innovation Growth Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, Osf Healthcare, Reimagined Ventures, Rising Tide Fund, Solasta Ventures, Tdk Ventures, Wanxiang Healthcare Investments | |
Price per Share
$xx.xx
Shares Outstanding
1,076,300
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Action Potential Venture Capital, Applied Ventures, Bold Capital, Creative Ventures, Fiscus Ventures, Innovation Growth Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, Osf Healthcare, Reimagined Ventures, Rising Tide Fund, Solasta Ventures, Tdk Ventures, Wanxiang Healthcare Investments
|
||||||
08/05/2019 | Series B | $36.67MM | $xx.xx | $120.46MM | Intel Capital, Osf Ventures | |
Price per Share
$xx.xx
Shares Outstanding
17,463,120
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Intel Capital, Osf Ventures
|
||||||
10/10/2017 | Series A | $6.82MM | $xx.xx | $48.56MM | Applied Ventures, Bold Capital Partners, Rising Tide | |
Price per Share
$xx.xx
Shares Outstanding
8,476,902
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Applied Ventures, Bold Capital Partners, Rising Tide
|
||||||
10/10/2017 | Series A+ | $7.65MM | $xx.xx | $48.56MM | Applied Ventures, Bold Capital Partners, Rising Tide | |
Price per Share
$xx.xx
Shares Outstanding
5,506,304
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Applied Ventures, Bold Capital Partners, Rising Tide
|